Related Experiment Videos
New perspectives in mucosal immunity with emphasis on vaccine development
J R McGhee1, K Fujihashi, J Xu-Amano
1Department of Microbiology, University of Alabama at Birmingham 35294-0005.
Seminars in Hematology
|October 1, 1993
Summary
This review highlights five key areas for developing oral vaccines, focusing on mucosal immunity and helper T-cell subsets for effective IgA responses and memory cell formation.
Area of Science:
- Immunology
- Vaccinology
Background:
- The mucosal immune system comprises inductive sites for antigen presentation and effector tissues for immune cell function.
- Helper T-cell (Th) subsets and cytokines are crucial for regulating mucosal IgA responses.
- The common mucosal immune system (CMIS) involves the migration of immune cells between inductive and effector sites.
Purpose of the Study:
- To review five critical areas for developing effective mucosal and systemic immunity to oral vaccines.
- To explore the roles of T-helper cell subsets, cytokines, and antigen presentation in mucosal immunity.
- To assess the significance of immunological memory and the extent of immunity induced by oral immunization.
Main Methods:
- Review of current research on mucosal immunity and oral vaccine development.
- Analysis of T-helper cell subsets (Th1, Th2) and their role in IgA production.
- Examination of antigen uptake, presentation, and immune cell trafficking within the mucosal immune system.
Main Results:
- Helper T-cells and cytokines are essential for mucosal IgA responses.
- Antigen uptake and presentation occur at inductive sites, leading to B and T cell activation.
- Memory B cells and T cells migrate to effector tissues, differentiating into IgA plasma cells, a hallmark of mucosal immunity.
Conclusions:
- Understanding Th cell subsets, antigen presentation, and memory is vital for oral vaccine design.
- The common mucosal immune system (CMIS) provides a framework for developing vaccines that induce broad mucosal immunity.
- Further research into these five areas will significantly advance oral vaccine development.